The Wall Street Journal: FDA staff takes no position on Moderna’s COVID booster

The Wall Street Journal: FDA staff takes no position on Moderna’s COVID booster
Food and Drug Administration staffers didn’t take a firm stance on Moderna Inc.’s application for a booster dose, indicating there may not be sufficient data to support the extra dose.

news

Visit AmericanStockTrader.com!